Masami Ikehata - Renal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

基本信息

浏览量：15

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 83 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Neurofibromatosis Type I (NF1) and Bone Involvement in a Pediatric Setting: Insights from FGF23 Levels

Giulia Rodari,Valeria Citterio,Masami Ikehata,Deborah Mattinzoli,Giulietta Scuvera,Federico Grilli,Eriselda Profka,Federico Giacchetti,Valentina Collini,Alessandro Risio,Claudia Cesaretti,Federica Natacci,Carlo Alfieri,Giovanna Mantovani,Claudia Giavoli

Italian Journal of Pediatricsno. 1 (2025): 1-11

引用0浏览0WOS引用

Potential Targeting of Upar-Fpr Signaling to Prevent Recurrence in Post-Transplant Primary Podocytopathies

Deborah Mattinzoli,Masami Ikehata,Daniele D'Alonzo, Maria De Fenza, Alberto Diana, Min Li,Silvia Armelloni,Antonella Tosoni,Alessandro Del Gobbo, Federica Collino, Antonio Mastrangelo,William Morello, Francesca Zanoni, Gaia Bianchi,Carlo Alfieri,Piergiorgio Messa, Manuela Nebuloni,Giovanni Montini,Luca Del Giacco,Vincenzo Pavone, Manuel Alfredo Podestà,Giuseppe Castellano

American journal of transplantation official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2025)

引用0浏览0WOS引用

Pharmacologic Inhibition of Urokinase-Type Plasminogen Activator Receptor (Upar)-Formyl Peptide Receptor (FPR) Signaling Prevents Podocyte Damage in Primary Podocytopathies

Manuel Alfredo Podesta',Deborah Mattinzoli,Masami Ikehata, Min Li,Silvia Armelloni,Francesca Zanoni,Carlo Alfieri,Piergiorgio Messa, Alberto Diana,Luca Del Giacco, Vincenzo Pavone,Giuseppe Castellano

Journal of the American Society of Nephrologyno. 10S (2024)

引用0浏览0引用

#1219 Extracellular Vesicles from Patients with AMR-induced Reprogramming of Human Podocytes into Senescent Cells: Role of SGLT2i

Giuseppe Castellano,Silvia Armelloni,Deborah Mattinzoli,Min LI,Masami Ikehata,Carlo Alfieri,Matteo Abinti

Nephrology Dialysis Transplantationno. Supplement_1 (2024)

引用0浏览0引用

Plasma-Derived Extracellular Vesicles of Antibody-Mediated Allograft Rejection Kidney Transplant Patients Mediate Reprogramming of Human Podocytes: Role of SGLT2 Inhibitors

Giuseppe Castellano,Silvia Armelloni,Deborah Mattinzoli, Min Li,Masami Ikehata,Valentina Bollati,Matteo Abinti, Manuel Alfredo Podesta',Carlo Alfieri

Journal of the American Society of Nephrologyno. 10S (2024)

引用0浏览0引用

Sequential Administration of Anti-Complement Component C5 Eculizumab and Type-2 Anti-Cd20 Obinutuzumab for the Treatment of Early Antibody-Mediated Rejection after Kidney Transplantation: A Proof of Concept

Evaldo Favi,Donata Cresseri,Marta Perego,Masami Ikehata,Samuele Iesari,Maria Rosaria Campise,William Morello,Sara Testa,Viviana Sioli,Deborah Mattinzoli,Elena Longhi,Alessandro Del Gobbo,Giuseppe Castellano,Mariano Ferraresso

CLINICAL IMMUNOLOGY (2024)

引用0浏览0WOS引用

Extracellular Vesicles from Patients with AMR-induced Reprogramming of Human Podocytes into Senescent Cells: Role of SGLT2i

Giuseppe Castellano,Silvia Armelloni,Deborah Mattinzoli, Min Li,Masami Ikehata,Carlo Alfieri,Matteo Abinti

NEPHROLOGY DIALYSIS TRANSPLANTATION (2024): I317-I317

引用0浏览0引用

Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease

Matteo Abinti,Simone Vettoretti,Lara Caldiroli,Deborah Mattinzoli,Masami Ikehata,Silvia Armelloni,Paolo Molinari,Carlo Maria Alfieri,Giuseppe Castellano,Piergiorgio Messa

Journal of Clinical Medicine（2024）

引用1浏览0WOS引用

Targeted Silencing of GNAS in a Human Model of Osteoprogenitor Cells Results in the Deregulation of the Osteogenic Differentiation Program

Francesca Marta Elli,Deborah Mattinzoli,Masami Ikehata, Francesca Bagnaresi,Maria A. Maffini,Giulia Del Sindaco,Angela Pagnano,Camilla Lucca,Piergiorgio Messa,Maura Arosio,Giuseppe Castellano,Carlo M. Alfieri,Giovanna Mantovani

Frontiers in Endocrinology (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn